{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:22Z","timestamp":1792705762767,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083198"],"award-info":[{"award-number":["1083198"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1130273"],"award-info":[{"award-number":["1130273"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136130"],"award-info":[{"award-number":["1136130"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083198"],"award-info":[{"award-number":["1083198"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1130273"],"award-info":[{"award-number":["1130273"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1108352"],"award-info":[{"award-number":["1108352"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["543706"],"award-info":[{"award-number":["543706"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["488817"],"award-info":[{"award-number":["488817"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1033736"],"award-info":[{"award-number":["1033736"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1052400"],"award-info":[{"award-number":["1052400"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["543706"],"award-info":[{"award-number":["543706"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The endothelial cell adhesion molecule E-selectin is a key component of the bone marrow hematopoietic stem cell (HSC) vascular niche regulating balance between HSC self-renewal and commitment. We now report in contrast, E-selectin directly triggers signaling pathways that promote malignant cell survival and regeneration. Using acute myeloid leukemia (AML) mouse models, we show AML blasts release inflammatory mediators that upregulate endothelial niche E-selectin expression. Alterations in cell-surface glycosylation associated with oncogenesis enhances AML blast binding to E-selectin and enable promotion of pro-survival signaling through AKT\/NF-\u03baB pathways. In vivo AML blasts with highest E-selectin binding potential are 12-fold more likely to survive chemotherapy and main contributors to disease relapse. Absence (in\n                    <jats:italic>Sele<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    hosts) or therapeutic blockade of E-selectin using small molecule mimetic GMI-1271\/Uproleselan effectively inhibits this niche-mediated pro-survival signaling, dampens AML blast regeneration, and strongly synergizes with chemotherapy, doubling the duration of mouse survival over chemotherapy alone, whilst protecting endogenous HSC.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-15817-5","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T06:03:17Z","timestamp":1587967397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance"],"prefix":"10.1038","volume":"11","author":[{"given":"Valerie","family":"Barbier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8356-9152","authenticated-orcid":false,"given":"Johanna","family":"Erbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Fiveash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-6047","authenticated-orcid":false,"given":"Julie M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-0537","authenticated-orcid":false,"given":"Joshua","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Tallack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar R.","family":"Pattabiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-7198","authenticated-orcid":false,"given":"John E. J.","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-6025","authenticated-orcid":false,"given":"Jean-Pierre","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-3572","authenticated-orcid":false,"given":"Ingrid G.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"15817_CR1","doi-asserted-by":"publisher","first-page":"e60823","DOI":"10.1371\/journal.pone.0060823","volume":"8","author":"B Pezeshkian","year":"2013","unstructured":"Pezeshkian, B., Donnelly, C., Tamburo, K., Geddes, T. & Madlambayan, G. J. Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism. PLoS ONE 8, e60823 (2013).","journal-title":"PLoS ONE"},{"key":"15817_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.leu.2404432","volume":"21","author":"M Ninomiya","year":"2006","unstructured":"Ninomiya, M. et al. Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia 21, 136\u2013142 (2006).","journal-title":"Leukemia"},{"key":"15817_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nbt1350","volume":"25","author":"F Ishikawa","year":"2007","unstructured":"Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315\u20131321 (2007).","journal-title":"Nat. Biotechnol."},{"key":"15817_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","volume":"495","author":"L Ding","year":"2013","unstructured":"Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231\u2013235 (2013).","journal-title":"Nature"},{"key":"15817_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding, L., Saunders, T. L., Enikolopov, G. & Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457\u2013462 (2012).","journal-title":"Nature"},{"key":"15817_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/nm.2969","volume":"18","author":"IG Winkler","year":"2012","unstructured":"Winkler, I. G. et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat. Med. 18, 1651\u20131657 (2012).","journal-title":"Nat. Med."},{"key":"15817_CR7","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1182\/blood.V88.9.3259.bloodjournal8893259","volume":"88","author":"GS Kansas","year":"1996","unstructured":"Kansas, G. S. Selectins and their ligands: current concepts and controversies. Blood 88, 3259\u20133287 (1996).","journal-title":"Blood"},{"key":"15817_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.1771409","volume":"23","author":"J Zuber","year":"2009","unstructured":"Zuber, J. et al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 23, 877\u2013889 (2009).","journal-title":"Genes Dev."},{"key":"15817_CR9","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2012-02-413187","volume":"123","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman, D. R. et al. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes. Blood 123, 2682\u20132690 (2014).","journal-title":"Blood"},{"key":"15817_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10719-016-9755-2","volume":"34","author":"BN Vajaria","year":"2017","unstructured":"Vajaria, B. N. & Patel, P. S. Glycosylation: a hallmark of cancer. Glycoconj. J. 34, 147\u2013156 (2017).","journal-title":"Glycoconj. J."},{"key":"15817_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/bies.201200111","volume":"35","author":"J-P Levesque","year":"2013","unstructured":"Levesque, J.-P., Winkler, I. G. & Rasko, J. E. J. Nichotherapy for stem cells: there goes the neighborhood. Bioessays 35, 183\u2013190 (2013).","journal-title":"Bioessays"},{"key":"15817_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<317::AID-PATH670>3.0.CO;2-O","volume":"180","author":"U Henseleit","year":"1996","unstructured":"Henseleit, U. et al. E-selectin expression in experimental models of inflammation in mice. J. Pathol. 180, 317\u2013325 (1996).","journal-title":"J. Pathol."},{"key":"15817_CR13","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1073\/pnas.88.15.6523","volume":"88","author":"KF Montgomery","year":"1991","unstructured":"Montgomery, K. F. et al. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl Acad. Sci. USA 88, 6523\u20136527 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15817_CR14","doi-asserted-by":"crossref","first-page":"15176","DOI":"10.1016\/S0021-9258(18)42162-X","volume":"267","author":"A Weller","year":"1992","unstructured":"Weller, A., Isenmann, S. & Vestweber, D. Cloning of the mouse endothelial selectins. Expression of both E- and P\u2212selectin is inducible by tumor necrosis factor alpha. J. Biol. Chem. 267, 15176\u201315183 (1992).","journal-title":"J. Biol. Chem."},{"key":"15817_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","volume":"43","author":"S Binder","year":"2018","unstructured":"Binder, S., Luciano, M. & Horejs-Hoeck, J. The cytokine network in acute myeloid leukemia (AML): a focus on pro- and anti-inflammatory mediators. Cytokine Growth Factor Rev. 43, 8\u201315 (2018).","journal-title":"Cytokine Growth Factor Rev."},{"key":"15817_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.20130990","volume":"211","author":"A Volk","year":"2014","unstructured":"Volk, A. et al. Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML. J. Exp. Med. 211, 1093\u20131108 (2014).","journal-title":"J. Exp. Med."},{"key":"15817_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2014-07-588590","volume":"125","author":"N Mondal","year":"2015","unstructured":"Mondal, N. et al. ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes. Blood 125, 687\u2013696 (2015).","journal-title":"Blood"},{"key":"15817_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1182\/blood-2012-04-424366","volume":"120","author":"WH Yang","year":"2012","unstructured":"Yang, W. H., Nussbaum, C., Grewal, P. K., Marth, J. D. & Sperandio, M. Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands. Blood 120, 1015\u20131026 (2012).","journal-title":"Blood"},{"key":"15817_CR19","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1074\/jbc.M112.400929","volume":"288","author":"A Buffone Jr.","year":"2013","unstructured":"Buffone, A. Jr. et al. Silencing alpha1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectin-mediated cell adhesion. J. Biol. Chem. 288, 1620\u20131633 (2013).","journal-title":"J. Biol. Chem."},{"key":"15817_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0092-8674(00)80137-3","volume":"86","author":"P Maly","year":"1996","unstructured":"Maly, P. et al. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86, 643\u2013653 (1996).","journal-title":"Cell"},{"key":"15817_CR21","doi-asserted-by":"publisher","first-page":"10231","DOI":"10.1073\/pnas.172380699","volume":"99","author":"S Hakomori","year":"2002","unstructured":"Hakomori, S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl Acad. Sci. USA 99, 10231\u201310233 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15817_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00432-018-2761-y","volume":"145","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma. J. Cancer Res. Clin. Oncol. 145, 65\u201376 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"15817_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.gene.2015.12.028","volume":"578","author":"X Feng","year":"2016","unstructured":"Feng, X. et al. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4. Gene 578, 232\u2013241 (2016).","journal-title":"Gene"},{"key":"15817_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biopha.2014.12.048","volume":"70","author":"X Yan","year":"2015","unstructured":"Yan, X., Lin, Y., Liu, S., Aziz, F. & Yan, Q. Fucosyltransferase IV (FUT4) as an effective biomarker for the diagnosis of breast cancer. Biomed. Pharmacother.70, 299\u2013304 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"15817_CR25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.15252\/msb.20177739","volume":"13","author":"N Auslander","year":"2017","unstructured":"Auslander, N. et al. An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer. Mol. Syst. Biol. 13, 956 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"15817_CR26","first-page":"2700","volume":"42","author":"D Li","year":"2018","unstructured":"Li, D. et al. alpha-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation. Int. J. Mol. Med. 42, 2700\u20132708 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"15817_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13046-019-1179-y","volume":"38","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. MiR-29b\/Sp1\/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt\/beta-catenin pathway in acute myeloid leukemia. J. Exp. Clin. Cancer Res. 38, 200 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"15817_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1349.001","volume":"1044","author":"JE Dick","year":"2005","unstructured":"Dick, J. E. Acute myeloid leukemia stem cells. Ann. N. Y. Acad. Sci. 1044, 1\u20135 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"15817_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1172\/JCI41495","volume":"121","author":"JE Sarry","year":"2011","unstructured":"Sarry, J. E. et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2Rgammac-deficient mice. J. Clin. Invest. 121, 384\u2013395 (2011).","journal-title":"J. Clin. Invest."},{"key":"15817_CR30","doi-asserted-by":"publisher","first-page":"17ra19","DOI":"10.1126\/scitranslmed.3000349","volume":"2","author":"Y Saito","year":"2010","unstructured":"Saito, Y. et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci. Transl. Med. 2, 17ra19 (2010).","journal-title":"Sci. Transl. Med."},{"key":"15817_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"15817_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.stem.2007.08.016","volume":"1","author":"LE Purton","year":"2007","unstructured":"Purton, L. E. & Scadden, D. T. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 1, 262\u2013270 (2007).","journal-title":"Cell Stem Cell"},{"key":"15817_CR33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1182\/blood.V98.4.1166","volume":"98","author":"GG Wulf","year":"2001","unstructured":"Wulf, G. G. et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98, 1166\u20131173 (2001).","journal-title":"Blood"},{"key":"15817_CR34","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax, C. et al. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc. Natl Acad. Sci. USA 101, 14228\u201314233 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15817_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1871520616666160729112854","volume":"17","author":"ML de Castro Barbosa","year":"2017","unstructured":"de Castro Barbosa, M. L. et al. NF-kappaB signaling pathway inhibitors as anticancer drug candidates. Anticancer Agents Med. Chem. 17, 483\u2013490 (2017).","journal-title":"Anticancer Agents Med. Chem."},{"key":"15817_CR36","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.4049\/jimmunol.170.7.3614","volume":"170","author":"KJ Stacey","year":"2003","unstructured":"Stacey, K. J. et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J. Immunol. 170, 3614\u20133620 (2003).","journal-title":"J. Immunol."},{"key":"15817_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1978","unstructured":"Raschke, W. C., Baird, S., Ralph, P. & Nakoinz, I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15, 261\u2013267 (1978).","journal-title":"Cell"},{"key":"15817_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285\u2013299 (2013).","journal-title":"Cell Stem Cell"},{"key":"15817_CR39","first-page":"1221","volume":"19","author":"P C","year":"2013","unstructured":"Pola, C. Leukemic cells hijack the niche. Nat. Med. 19, 1221 (2013).","journal-title":"Nat. Med."},{"key":"15817_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ijc.2910610404","volume":"61","author":"C Ye","year":"1995","unstructured":"Ye, C. et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J. Cancer 61, 455\u2013460 (1995).","journal-title":"Int J. Cancer"},{"key":"15817_CR41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/ijc.30538","volume":"140","author":"H Shi","year":"2017","unstructured":"Shi, H. et al. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1beta-mediated increase in E-selectin expression. Int J. Cancer 140, 1370\u20131383 (2017).","journal-title":"Int J. Cancer"},{"key":"15817_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41556-019-0309-2","volume":"21","author":"M Esposito","year":"2019","unstructured":"Esposito, M. et al. Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nat. Cell Biol. 21, 627\u2013639 (2019).","journal-title":"Nat. Cell Biol."},{"key":"15817_CR43","doi-asserted-by":"publisher","first-page":"14423","DOI":"10.1073\/pnas.95.24.14423","volume":"95","author":"PS Frenette","year":"1998","unstructured":"Frenette, P. S., Subbarao, S., Mazo, I. B., von Andrian, U. H. & Wagner, D. D. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc. Natl Acad. Sci. USA 95, 14423\u201314428 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15817_CR44","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1182\/blood-2003-04-1212","volume":"102","author":"Y Katayama","year":"2003","unstructured":"Katayama, Y. et al. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and \u03b14 integrin. Blood 102, 2060\u20132067 (2003).","journal-title":"Blood"},{"key":"15817_CR45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.exphem.2013.02.014","volume":"41","author":"LK Nabors","year":"2013","unstructured":"Nabors, L. K., Wang, L. D., Wagers, A. J. & Kansas, G. S. Overlapping roles for endothelial selectins in murine hematopoietic stem\/progenitor cell homing to bone marrow. Exp. Hematol. 41, 588\u2013596 (2013).","journal-title":"Exp. Hematol."},{"key":"15817_CR46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"15817_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10719-012-9448-4","volume":"29","author":"SI Hakomori","year":"2012","unstructured":"Hakomori, S. I. & Cummings, R. D. Glycosylation effects on cancer development. Glycoconj. J. 29, 565\u2013566 (2012).","journal-title":"Glycoconj. J."},{"key":"15817_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1074\/jbc.M109958200","volume":"277","author":"P Delmotte","year":"2002","unstructured":"Delmotte, P. et al. Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and\/or sulfated Lewis x epitopes in the human bronchial mucosa. J. Biol. Chem. 277, 424\u2013431 (2002).","journal-title":"J. Biol. Chem."},{"key":"15817_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1470","volume":"12","author":"NM Dagia","year":"2006","unstructured":"Dagia, N. M. et al. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat. Med. 12, 1185\u20131190 (2006).","journal-title":"Nat. Med."},{"key":"15817_CR50","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.4049\/jimmunol.1502434","volume":"197","author":"M Pink","year":"2016","unstructured":"Pink, M. et al. Imprinting of skin\/inflammation homing in CD4+ T cells is controlled by DNA methylation within the Fucosyltransferase 7 Gene. J. Immunol. 197, 3406\u20133414 (2016).","journal-title":"J. Immunol."},{"key":"15817_CR51","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1182\/blood-2003-09-3047","volume":"104","author":"U Syrbe","year":"2004","unstructured":"Syrbe, U. et al. Differential regulation of P-selectin ligand expression in naive versus memory CD4+ T cells: evidence for epigenetic regulation of involved glycosyltransferase genes. Blood 104, 3243\u20133248 (2004).","journal-title":"Blood"},{"key":"15817_CR52","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","volume":"108","author":"JG Turner","year":"2006","unstructured":"Turner, J. G. et al. ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood 108, 3881\u20133889 (2006).","journal-title":"Blood"},{"key":"15817_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-898","volume":"14","author":"R Henrique","year":"2013","unstructured":"Henrique, R. et al. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer. BMC Genomics 14, 898 (2013).","journal-title":"BMC Genomics"},{"key":"15817_CR54","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/1878-0261.12163","volume":"12","author":"MA Carrascal","year":"2018","unstructured":"Carrascal, M. A. et al. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1\/2 and p38 MAPK activation. Mol. Oncol. 12, 579\u2013593 (2018).","journal-title":"Mol. Oncol."},{"key":"15817_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3324\/haematol.2012.069260","volume":"98","author":"IG Winkler","year":"2013","unstructured":"Winkler, I. G. et al. B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2. Haematologica 98, 325\u2013333 (2013).","journal-title":"Haematologica"},{"key":"15817_CR56","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2003-06-1921","volume":"103","author":"IG Winkler","year":"2004","unstructured":"Winkler, I. G., Snapp, K. R., Simmons, P. J. & Levesque, J.-P. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1. Blood 103, 1685\u20131692 (2004).","journal-title":"Blood"},{"key":"15817_CR57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood-2012-02-408419","volume":"121","author":"CE Forristal","year":"2013","unstructured":"Forristal, C. E. et al. Pharmacologic stabilization of HIF-1\u03b1 increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation. Blood 121, 759\u2013769 (2013).","journal-title":"Blood"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15817-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:04:12Z","timestamp":1670256252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15817-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15817"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15817-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GlycoMimetics provided funding for some parts of this project involving use of GMI-1271 and toward purchase of flow cytometer used in these studies. V.B., J.E., C.F., J.M.D., J.T., M.R.T., J. Lowe, J. Lisle., D.R.B., A.C.P, J.L., J.E.J.R. and I.G.W. declare no other competing interests. J.L.M. is employed by and owns shares in GlycoMimetics Inc. J.P.L. owns shares in GlycoMimetics Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2042"}}